AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ALFACALCIDOL
8 registrations across 3 African markets— 5 active
Markets with ALFACALCIDOL
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| UN-ALFA Capsule Orale / 1 µG | 🇹🇳Tunisia | CHEPLAPHARM Arzneimittel GmbH | expired | Jan 2022 |
| UN-ALFA Capsule Orale / 0.25 µG | 🇹🇳Tunisia | CHEPLAPHARM Arzneimittel GmbH | expired | Jan 2022 |
| UN-ALFA Solution injectable / 1 µG/0.5 ml | 🇹🇳Tunisia | CHEPLAPHARM Arzneimittel GmbH | expired | Jan 2022 |
| UN-ALFA 1 µG CAPSULE | 🇲🇦Morocco | — | active | — |
| UN-ALFA 1 µG CAPSULE | 🇲🇦Morocco | — | active | — |
| UN-ALFA 0,25 µG CAPSULE | 🇲🇦Morocco | — | active | — |
| UN-ALFA 0,25 µG CAPSULE | 🇲🇦Morocco | — | active | — |
| Alfa-Vit D Concentrate For Oral Solution | 🇰🇪Kenya | Nischi Lifesciences | active | — |
ALFACALCIDOL in Africa — Regulatory Overview
ALFACALCIDOL is registered across 3 African markets with 8 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tunisia, Kenya. AfricaRegulatory refreshes this data daily from official government sources.
Of the 8 registrations, 5 (63%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.